Evaxion Biotech AS (EVAX)
1.63
+0.19
(+13.19%)
USD |
NASDAQ |
Nov 18, 16:00
1.78
+0.15
(+9.20%)
After-Hours: 20:00
Evaxion Biotech Price: 1.63 for Nov. 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 18, 2024 | 1.40 | 1.76 | 1.360 | 1.63 | 70071.00 |
Nov 15, 2024 | 1.63 | 1.70 | 1.40 | 1.44 | 76290.00 |
Nov 14, 2024 | 1.76 | 1.89 | 1.68 | 1.68 | 41395.00 |
Nov 13, 2024 | 2.34 | 2.34 | 1.59 | 1.76 | 181299.0 |
Nov 12, 2024 | 2.52 | 2.575 | 2.33 | 2.38 | 64177.00 |
Nov 11, 2024 | 2.43 | 2.63 | 2.41 | 2.42 | 28626.00 |
Nov 08, 2024 | 2.55 | 2.61 | 2.45 | 2.50 | 25556.00 |
Nov 07, 2024 | 2.58 | 2.680 | 2.54 | 2.62 | 25753.00 |
Nov 06, 2024 | 2.65 | 2.760 | 2.55 | 2.57 | 14973.00 |
Nov 05, 2024 | 2.65 | 2.65 | 2.566 | 2.61 | 2174.00 |
Nov 04, 2024 | 2.55 | 2.68 | 2.539 | 2.64 | 7974.00 |
Nov 01, 2024 | 2.58 | 2.634 | 2.55 | 2.59 | 11698.00 |
Oct 31, 2024 | 2.59 | 2.875 | 2.548 | 2.67 | 30671.00 |
Oct 30, 2024 | 2.91 | 2.961 | 2.76 | 2.76 | 9202.00 |
Oct 29, 2024 | 2.97 | 3.10 | 2.90 | 2.91 | 35376.00 |
Oct 28, 2024 | 2.799 | 2.976 | 2.76 | 2.84 | 14816.00 |
Oct 25, 2024 | 2.65 | 2.80 | 2.65 | 2.76 | 6417.00 |
Oct 24, 2024 | 2.69 | 2.82 | 2.566 | 2.65 | 14688.00 |
Oct 23, 2024 | 2.582 | 2.702 | 2.58 | 2.67 | 12971.00 |
Oct 22, 2024 | 2.77 | 2.77 | 2.56 | 2.56 | 20629.00 |
Oct 21, 2024 | 2.66 | 2.76 | 2.50 | 2.54 | 10823.00 |
Oct 18, 2024 | 2.74 | 2.80 | 2.64 | 2.64 | 8720.00 |
Oct 17, 2024 | 2.81 | 2.82 | 2.71 | 2.71 | 4903.00 |
Oct 16, 2024 | 2.75 | 2.812 | 2.70 | 2.71 | 18994.00 |
Oct 15, 2024 | 2.69 | 2.71 | 2.58 | 2.60 | 13559.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.44
Minimum
Nov 15 2024
126.80
Maximum
Nov 04 2021
26.99
Average
17.40
Median
May 13 2022
Price Benchmarks
Ascendis Pharma AS | 122.00 |
DBV Technologies SA | 0.51 |
Adaptimmune Therapeutics PLC | 0.595 |
Akari Therapeutics PLC | 2.29 |
Biodexa Pharmaceuticals PLC | 3.65 |
Price Related Metrics
PS Ratio | 2.258 |
Price to Book Value | 122.87 |
Earnings Yield | -171.8% |
Market Cap | 9.092M |